Sergey Yurasov

发表

Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial

Andreas Sashegyi, Michael Thomas, Federico Cappuzzo, 2014, The Lancet.

Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning.

Michel C Nussenzweig, Hedda Wardemann, M. Nussenzweig, 2008, Journal of immunological methods.